The challenges Prof. Bruce Johnson will be faced with as the president of ASCO
How can we improve our understanding of the progression of myeloma?
Results of KEYNOTE-023 and pembrolizumab plus pomalidomide trials for multiple myeloma
Jesús San Miguel
Embracing the use of social media at medical congresses
Phase I trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma